Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Centre
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
Communication
In the News
Presentations
Contact Us
Contact Us
Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
24 Jun 2019
Dr John Lambert appointed as new CEO
17 Jun 2019
Preliminary Rights Issue Details
14 Jun 2019
Placement Cleansing Notice
14 Jun 2019
Appendix 3B - Placement $360k
12 Jun 2019
Capital Raising for Clinical-Enabling Studies
29 May 2019
Preliminary Final Report - Year Ended 31 March 2019
30 Apr 2019
Appendix 4C - Quarterly Statement of Cash Flows
01 Apr 2019
European Patent Completes IP Protection in Major Markets
11 Mar 2019
Amplia Expands Advisory Board
12 Feb 2019
Update - February 2019 Newsletter
Previous
1
2
3
4
